Table 1 Data of the study population was divided into two groups according to aspirin therapy after matching
From: Aspirin reduces the risk of type 2 diabetes associated with COVID-19
Variable | No aspirin N = 4139 | Aspirin N = 4139 | Difference | 95% CI |
|---|---|---|---|---|
Age (years) | 76 | 76 | −0.03 | −0.07, 0.02 |
Gender | 0.00 | −0.04, 0.05 | ||
F | 2274 (55%) | 2284 (55%) | ||
M | 1865 (45%) | 1855 (45%) | ||
Prediabetes (N) | 1560 (38%) | 1635 (40%) | −1.8% | −3.9%, 0.31% |
BMI (kg/m2) | 27.1 | 27.0 | 0.03 | −0.01, 0.08 |
Statins (N) | 3018 (73%) | 3058 (74%) | −0.97% | −2.9%, 0.96% |
Antihypertensives (N) | 3332 (81%) | 3314 (80%) | 0.43% | −1.3%, 2.2% |
